| Literature DB >> 7224913 |
Abstract
Five hundred patients with cysticercosis of the nervous system were evaluated by scanning that used anti-Cysticercus antibodies labeled with indium 113. The same antibodies, labeled with iodine 131, were used for radioimmunotreatment. Ninety-six percent of the patients had good or excellent results, whereas only 4% had poor results. None of the patients showed intolerance or radiotoxicity during three months of clinical and laboratory follow-up. The diagnosis, treatment, and prognosis of cysticercosis of the nervous system are dramatically changing, due to the development of anti-Cysticercus antibodies labeled with radionuclides.Entities:
Mesh:
Substances:
Year: 1981 PMID: 7224913 DOI: 10.1001/archneur.1981.00510050054007
Source DB: PubMed Journal: Arch Neurol ISSN: 0003-9942